Meropenem

美洛培南

Report date: 2026/03/31 20:00:21
NME

Base Information

Drug NameMeropenem
Drug Alias NameMerozem美罗培兰Meropenemum美洛配能美罗培南 +[15] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Carbapenems antibioticsSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsComplicated Skin and Soft Tissue InfectionsFebrile NeutropeniaMeningitis +[14] 
Global Approved IndicationsFebrile NeutropeniaIntraabdominal InfectionsMeningitis, Bacterial +[4] 
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryJapan
Original Approved Date1995/09/04
Country/TerritoryUnited StatesSingaporeSaudi Arabia +[11] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSumitomo Dainippon Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSumitomo DainipponZhejiang Hisun Pharmaceutical Co LtdAin Shams University +[4] 
Inactive CompaniesThe University Of QueenslandMelinta Therapeutics IncPenta Global Foundation Pte Ltd +[7] 
Active IndicationsFebrile NeutropeniaSepsisBacterial Infections
Inactive IndicationsComplicated Skin and Soft Tissue InfectionsMeningitisAbscess +[11] 

Other Information

ATC CodeJ01DH02
Related LinksWikipediaDrugBankKEGG